Purchases and Sales Made in Q3 2022 in Effector Therapeutics Inc (EFTRW)
This table provides information about the institutional ownership of Effector Therapeutics Inc (EFTRW) during Q3 2022. The information is specifically focused on institutions that hold shares of EFFECTOR THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
125K+ 24.73% |
$10K - $35K
|
631K
$0
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
125K+ 24.73% |
$10K - $35K
|
631K
$0
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Wolverine Asset Management LLC
|
SELL
|
- |
-5.87K- 32.22% |
$470 - $1.64K
|
12.4K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Cvi Holdings, LLC
Wilmington, DE |
SELL
|
- |
-17.6K- 26.13% |
$1.41K - $4.93K
|
49.7K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-56.6K- 3.51% |
$4.53K - $15.9K
|
1.56M
$0
|